Filing Details

Accession Number:
0001140361-22-043128
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2022-11-25 16:26:46
Reporting Period:
2022-11-22
Accepted Time:
2022-11-25 16:26:46
Original Submission Date:
2022-11-23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1610853 Helius Medical Technologies Inc. HSDT () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201810 Dane Andreeff C/O Helius Medical Technologies, Inc.
642 Newtown Yardley Road, Suite 100
Newtown PA 18940
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-22 10,300 $0.28 218,872 No 4 P Indirect See footnote
Common Stock Acquisiton 2022-11-23 42,185 $0.31 261,057 No 4 P Indirect See footnote
Common Stock Acquisiton 2022-11-23 10,105 $0.31 54,025 No 4 P Indirect See footnote
Common Stock Acquisiton 2022-11-23 30,841 $0.31 306,923 No 4 P Indirect See footnote
Common Stock Acquisiton 2022-11-23 2,509 $0.31 13,439 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,508 Direct
Footnotes
  1. This Form 4/A is being filed to amend an inadvertent error in the number of shares purchased by the Reporting Person in the Form 4 previously filed on November 23, 2022.
  2. The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
  3. The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities owned by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
  4. The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities owned by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
  5. The shares are held by Maple Leaf Offshore Ltd. ("MLO"). The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities owned by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.